JacquelineSGarciaMD

Oncology • Boston, MA

Hematologic Oncology

Attending Physician

Join to view full profile

Dr. Garcia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Garcia's full profile

Already have an account?

Office
450 Brookline Ave
# Dana
Boston, MA 02215
Phone+1 650-632-1906

Fax+1 617-582-9806

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2011 - 2015
University of ChicagoResidency, Internal Medicine, 2008 - 2011
University of Illinois College of MedicineClass of 2008

Certifications & Licensure

CA State Medical License 2011 - Present
MA State Medical License 2015 - 2025
IL State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN Start of enrollment: 2018 Oct 24
Recruiting
Phase 1
Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts Start of enrollment: 2019 Aug 01
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms Start of enrollment: 2022 Jul 18
Recruiting
Phase 1
Roles: Sponsor-Investigator, Contact, Principal Investigator
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies Start of enrollment: 2018 Mar 19
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i) Start of enrollment: 2024 Jul 15
Not yet recruiting
Phase 1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

16 citations
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, Michael J Thirman, Jacqueline S Garcia
American Journal of Hematology. 2024-04-01
1 citations
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes.
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun
Leukemia. 2024-09-01
5 citations
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.
Emily C Wheeler, Benjamin J E Martin, William C Doyle, Sofia Neaher, Caroline A Conway
Science Translational Medicine. 2024-01-03

Journal Articles

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D Dinardo, Brian A Jonas, Jacqueline S Garcia, Anthony Letai, Wan-Jen Hong, Keith W Pratz, The New England Journal of Medicine

Abstracts/Posters

Talazoparib Treatment Preferentially Depletes Cohesin-Mutant Clones in New In Vivo Models of Cohesin-Mutant Myeloid Diseases
Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Results from a Phase 2 Study of Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis
Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Individualized Mitochondrial Functional Approach to Combination of BCL-2 and MCL-1 Antagonism in Acute Myeloid Leukemia
Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia
Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Incidence of Serious Adverse Events, Pneumonitis, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphom...
Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Multicenter Phase I Study Combining Venetoclax with Mini-Hyper-CVD in Older Adults with Untreated and Relapsed/Refractory Acute Lymphoblastic Leukemia
Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodyspl...
Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodyspl...
Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Authored Content

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaAugust 2020
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaAugust 2020
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaAugust 2020
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid LeukemiaAugust 2020
Join now to see all

Press Mentions

Days from California Reopening, Rules Still up in the AirJune 9th, 2021
Cancer News Digest: The Latest Developments in Cancer Research and Treatment for December 2020January 22nd, 2021
Close Quarters: California’s Overcrowded Homes Fuel Spread of Coronavirus Among WorkersJune 12th, 2020
Join now to see all